DJIA 18,203.37 -85.26 -0.47%
NASDAQ 4,979.90 -28.20 -0.56%
S&P 500 2,107.78 -9.61 -0.45%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)

2.79 0.02 (0.72%)

REAL-TIME: Last trade at

Extended Hours: $2.79 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

VVUS $2.79 0.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.75
Previous Close $2.77
Daily Range $2.69 - $3.03
52-Week Range $2.41 - $6.40
Market Cap $289.8M
P/E Ratio -3.46
Dividend (Yield) $0.00 (0.0%)
Volume 6,570,363
Average Daily Volume 1,936,869
Current FY EPS -$1.25

Sector

Healthcare

Industry

Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Why Orexigen Therapeutics, Inc. Stock Exploded Higher

Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.

Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit

Vivus - Flat Qsymia Scripts Point To Needed Shift

Vivus Sinking With Dwindling Qsymia Market Share

Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch

Fourth-quarter earnings were nothing to get excited about, but the Contrave launch trajectory looks good so far.

VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog

Why Vivus Inc Plummeted Today

Vivus Inc shares tanked today following results that failed to impress.

JPM Securities Picks Through Biotech News For Winners

See More VVUS News...

VVUS's Top Competitors

VVUS $2.79 (0.72%)
Current stock: VVUS
JNJ $102.34 (-0.85%)
Current stock: JNJ
NVS $99.06 (-1.01%)
Current stock: NVS
RHHBY $34.35 (1.07%)
Current stock: RHHBY